A new study published in The American Journal of Cardiology revealed acute total occlusion (ATO) in non-ST-segment elevation ...
CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...
A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...
Among patients with LVO-related AIS undergoing EVT, general anesthesia is linked to better 90-day recovery and functional independence vs sedation.
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment of the first patient in the ARTIZEN pivotal trial, evaluating the ...
Imperative Care, Inc. today announced the presentation of late-breaking, real-world data from a multi-center review of ischemic stroke patients treated with ADAPT 2.0, a next-generation approach to A ...
This month’s Legal Advisor documents a case of a patient becoming acutely ill while away, and the proper steps the nurse practitioner took while in the emergency department.
Medical Device Network on MSN
Sofinnova spinoff Tulyp Medical emerges from stealth with perfusion tech
Tulyp Medical has emerged from stealth with its pressure-driven perfusion system for vascular procedures and submitted a ...
A soldier chose to make his final sacrifice by donating his organs after brain death, giving hope of reviving eight patients waiting for transplants.
The PFA-SHAM trial and MANIFEST-US registry support the efficacy and safety of the increasingly used ablation modality.
A man in his 40s of Middle Eastern descent, with no prior medical history, presented with severe abdominal pain that had ...
LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results